本文へ

This website uses cookies for usage measurement and traffic analysis purposes.
By clicking the "Agree" button or continuing to browse this site, you consent to the use of cookies.
For more details, please refer to the Privacy Policy別ウィンドウで開く (opens in a new window).

Agree

ATLAS Asia Clinical Trials Network for Cancers Project
menu
  1. Home
  2. Member Search
  3. Nami SHIRAKAWA (白川 奈美)

Nami SHIRAKAWA (白川 奈美) , MD, PhD

Title (Affiliation)
Department of Pediactric Oncology, Researcher
Facility Name

National Cancer Center Hospital, Japan

Department Department of Pediatric Oncology
白川 奈美の写真

Dr. Shirakawa’s Story

I have been providing cancer treatment for children and AYAs at the National Cancer Center Hospital. The development of new drugs for pediatric oncology has been slow due to the fact that pediatric oncology is a rare cancer and drug metabolism is different from that of adults. Currently, I am involved in the development of new drugs so that more children can receive them. I am also interested in conducting research in cooperation with overseas countries to eliminate drug lag.

Research Interest

New drug development for pediatric oncology, international collaborative research in the pediatric field

Professional Experience

2022-present National Cancer Center Hospital, Clinical Research Support Office/Department of Pediactric Oncology, 
2017~2022 National Cancer Center Hospital, Department of Pediactric Oncology

Qualifications, certified physicians, medical specialists

Board Certified Pediatrician

Diplomate, Subspecialty Board of Medical Oncology

General Clinical Oncologist

PAGE TOP